
03 Feb 2022 Fundraising
Leukaemia UK awarded Christmas Grant to support life-saving research
Leukaemia UK are delighted to have been awarded a special Christmas Grant from Kusuma Trust UK.
The grant of £10,000 will support the life-saving leukaemia research projects that Leukaemia UK funds across the UK. This includes Leukaemia UK’s prestigious John Goldman Fellowships which fund novel research projects by early career researchers into treatments for leukaemia and Project Grants funding experienced researchers advancing the fundamental understanding of the disease.
Fiona Hazell, Chief Executive of Leukaemia UK, said “We are thrilled to have been awarded this grant from Kusuma Trust UK, which will help to support Leukaemia UK’s life-saving research programmes into kinder and more effective treatments. Kusuma Trust’s support will help us to progress the research that matters most to the tens of thousands of families impacted by a leukaemia diagnosis.”
The Kusuma Trust UK is a family led philanthropic trust established in 2010. The Trust gives grants to organisations based on shared values and mutual interests in the UK, Gibraltar and India. Its current areas of interest are creating access to opportunities, improving health and well-being, and investing in our communities and environment.”
The Kusuma Trust said “We were very impressed to learn about Leukaemia UK’s research into leukaemia and other blood cancers and related disorders, and how they are pioneering the development of improved care and support to those affected. We hope that our funding will help to continue doing this important work.”
This generous grant will go towards funding kinder and more effective treatments for leukaemia, such as the research being carried out by Dr Samanta Mariani into the role of macrophages in cases of infant leukaemia or by Dr Daniel Coleman into developing kinder treatments by targeting mutated RAS genes.
Related posts
15 June 2018
MP opens Leukaemia UK Ambulatory Care Unit
A unit funded by Leukaemia UK which allows people with blood cancer to have stem cell transplants as out-patients has been officially opened by its first patient, Nick Boles MP
21 April 2023
Trailblazing research project announced to exploit novel weaknesses in one of the least survivable cancers
A pioneering new study hopes to accelerate progress towards a new treatment for acute myeloid leukaemia (AML) in research announced today on World AML Day by Leukaemia UK. University of…
11 January 2019
Leukaemia UK and Leuka have merged
We are delighted to announce that on 1 November Leuka and Leukaemia UK merged
18 September 2025
1 in 4 leukaemia patients in England experiences an avoidable delay in diagnosis
A first of its kind study, commissioned by Leukaemia UK, has revealed that a quarter (26%) of leukaemia patients in England experience avoidable delays in their diagnosis, resulting in a…